Floatz logo

10 assets in Crohn Disease

Therapeutic assets addressing Crohn Disease, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dexasone
Crohn Disease
University of SaskatchewanP4BB (70)
Oxygen
Crohn Disease
Jay C. Buckey Jr.P4BB (64)
Mirikizumab
Crohn Disease
Eli Lilly and CompanyP3B (60)
Tirzepatide
Crohn Disease
Eli Lilly and CompanyP3B (60)
Cyclophosphamide
Crohn Disease
Tr1X, Inc.P1/2CCC (48)
trx103
Crohn Disease
Tr1X, Inc.P1/2CCC (48)
Cabozantinib
Crohn Disease
National Cancer Institute (NCI)P1CC (43)
Ipilimumab
Crohn Disease
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Crohn Disease
National Cancer Institute (NCI)P1CC (43)
[68ga]ga-dota-cys-ath001
Crohn Disease
Antaros MedicalEarly P1NR ()